Symptomatic improvement · mostly women with dry eye syndrome
1 finding from 1 review
Ocular surface staining · mostly women with dry eye syndrome
1 finding from 1 review
Aqueous tear production · mostly women with dry eye syndrome
1 finding from 1 review
Tear film stability · mostly women with dry eye syndrome
1 finding from 1 review
Artificial tear use · mostly women with dry eye syndrome
1 finding from 1 review
Adverse events · mostly women with dry eye syndrome
1 finding from 1 review
Symptomatic improvement · adults with dry eye syndrome
1 finding from 1 review
Ocular surface staining · adults with dry eye syndrome
1 finding from 1 review
Aqueous tear production · adults with dry eye syndrome
1 finding from 1 review
Tear film stability · adults with dry eye syndrome
1 finding from 1 review
Artificial tear use · adults with dry eye syndrome
1 finding from 1 review
Adverse events · adults with dry eye syndrome
1 finding from 1 review
Intraocular inflammation measured by anterior chamber cell and flare 1 week · people who received phacoemulsification
1 finding from 1 review
Intraocular inflammation measured by proportion of participants with corneal edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs showed no clear difference in intraocular inflammation measured by proportion of participants with… compared with corticosteroids (low certainty).
1 finding from 1 review
Proportion of participants with best‐corrected visual acuity of 20/40 1 week · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with cystoid macular edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs may leads to lower proportion of participants with cystoid macular edema 1 week compared with corticosteroids (low certainty).
1 finding from 1 review
Time to cessation of treatment · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic outcomes · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in visual acuity at 1 year (number of letters) · people with neovascular age‐related macular degeneration
Summary of findings: bevacizumab showed no clear difference in mean change in visual acuity at 1 year (number of letters) compared with ranibizumab (high certainty).
1 finding from 1 review